These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 669855)

  • 1. The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems.
    Hurwitz E; Maron R; Bernstein A; Wilchek M; Sela M; Arnon R
    Int J Cancer; 1978 Jun; 21(6):747-55. PubMed ID: 669855
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
    Arnon R; Sela M
    Immunol Rev; 1982; 62():5-27. PubMed ID: 7042540
    [No Abstract]   [Full Text] [Related]  

  • 3. Higher antitumor efficacy of daunomycin when linked to dextran: in vivo and in vitro studies.
    Bernstein A; Hurwitz E; Maron R; Arnon R; Sela M; Wilchek M
    J Natl Cancer Inst; 1978 Feb; 60(2):379-84. PubMed ID: 621754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of tumour specific antibodies with chlorambucil.
    Davies DA; O'Neill GJ
    Br J Cancer Suppl; 1973 Aug; 1():285-98. PubMed ID: 4548355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
    Hurwitz E; Levy R; Maron R; Wilchek M; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1175-81. PubMed ID: 164279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitumor activity of adriamycin].
    Kitaura K; Watanabe Y; Ishihara Y; Takahira H
    Jpn J Antibiot; 1972 Apr; 25(2):65-71. PubMed ID: 4341940
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies as carriers for oncostatic materials.
    Arnon R; Hurwitz E; Sela M
    Recent Results Cancer Res; 1980; 75():236-45. PubMed ID: 6165055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti cancer effect of antibiotic-AFP-purified antibody conjugates].
    Tsukada Y; Hibi N; Ohkawa K; Uchino J; Hirai H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2653-8. PubMed ID: 6210058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental studies on antineoplastic activity of daunomycin. I. Effect on experimental tumors].
    Nomiya B; Kagino K; Orikawa Y; Fujimori H
    Jpn J Antibiot; 1970 Apr; 23(2):171-80. PubMed ID: 5311043
    [No Abstract]   [Full Text] [Related]  

  • 12. Covalent binding of methotrexate to immunoglobulins and the effect of antibody-linked drug on tumor growth in vivo.
    Kulkarni PN; Blair AH; Ghose TI
    Cancer Res; 1981 Jul; 41(7):2700-6. PubMed ID: 7248938
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexes.
    De Weger RA; Dullens HF; Den Otter W
    Immunol Rev; 1982; 62():28-45. PubMed ID: 7042539
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy with daunorubicin-anti-CEA conjugates in human colon adenocarcinoma grafted in nude mice.
    Pagé M; Delorme F; Lafontaine F; Dumas L
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):56-8. PubMed ID: 6505718
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed chemotherapy with a drug bound to anti-idiotypic antibody to a lymphoma cell-surface IgM.
    Hurwitz E; Kashi R; Burowsky D; Arnon R; Haimovich J
    Int J Cancer; 1983 Jun; 31(6):745-8. PubMed ID: 6862683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective antitumour conjugates of alkylating drug and antibody using dextran as the intermediate carrier.
    Rowland GF
    Eur J Cancer (1965); 1977 Jun; 13(6):593-6. PubMed ID: 880966
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effect of DEAE-dextran on tumour growth. (1). Action of dextran sulphate after "in vitro" incubation.
    Larsen B; Thorling EB
    Acta Pathol Microbiol Scand; 1969; 75(2):229-36. PubMed ID: 5822962
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth characteristics of MOPC-315 plasmacytoma and response to anticancer agents.
    Valeriote F; Lynch R; Berger NA; White E; Coulter D
    J Natl Cancer Inst; 1981 Jun; 66(6):1083-8. PubMed ID: 7017213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexes and conjugates of cis-Pt for immunotargeted chemotherapy.
    Arnon R; Schechter B; Wilchek M
    Adv Exp Med Biol; 1991; 303():79-90. PubMed ID: 1725240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.